Recipient
Virica Biotech Inc.Department
National Research Council CanadaAmount
$354.2K
Province
ONType
Contribution
Agreement Number
172-2025-2026-Q2-1034570
Purpose
As part of the international consortium project “UK Multisector – BioM - LV Production Kit: Development of GMP lentiviral production kit with optimized upstream and downstream processes” this project will develop an end-to-end and off-the-shelf GMP enabled lentivirus manufacturing kit. The current standard in lentivirus manufacturing is inefficient and delivers low yields, leading to elevated manufacturing costs and less accessible therapeutics. This kit will be the first of its kind, integrating innovative upstream and downstream technologies that have been demonstrated to significantly enhance both upstream manufacturing yields and downstream processing recovery and contributing to the greater accessibility of ex-vivo gene therapy.
Virica Biotech Inc. × National Research Council Canada
10 grants totalling $1.3M
Industrial Research Assistance Program – Contributions to Firms
1,000 grants totalling $112.4M
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| Providence Therapeutics Holdings Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Laurent Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Laurent Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |